These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28339290)

  • 1. Preventing the spread of infectious diseases: antivirulents versus antibiotics.
    Shoham M; Greenberg M
    Future Microbiol; 2017 Apr; 12():365-368. PubMed ID: 28339290
    [No Abstract]   [Full Text] [Related]  

  • 2. Key pathogens and emerging therapies in infectious diseases.
    Miller PF; Mueller JP
    Curr Opin Pharmacol; 2009 Oct; 9(5):535-6. PubMed ID: 19766536
    [No Abstract]   [Full Text] [Related]  

  • 3. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
    Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
    Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report calls for $2bn global fund to kickstart antibiotic development.
    Wise J
    BMJ; 2015 May; 350():h2635. PubMed ID: 25975228
    [No Abstract]   [Full Text] [Related]  

  • 5. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation.
    Ponziani FR; Zocco MA; D'Aversa F; Pompili M; Gasbarrini A
    World J Gastroenterol; 2017 Jul; 23(25):4491-4499. PubMed ID: 28740337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Child-care practices: effects of social change on the epidemiology of infectious diseases and antibiotic resistance.
    Holmes SJ; Morrow AL; Pickering LK
    Epidemiol Rev; 1996; 18(1):10-28. PubMed ID: 8877328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.
    Brannon JR; Hadjifrangiskou M
    Drug Des Devel Ther; 2016; 10():1795-806. PubMed ID: 27313446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance: An infectious arms race.
    Hede K
    Nature; 2014 May; 509(7498):S2-3. PubMed ID: 24784426
    [No Abstract]   [Full Text] [Related]  

  • 9. [The statement from 6 infectious diseases-related academic societies towards the further understanding of the necessity for the innovation/development of novel antimicrobials and the current status of antibiotic-resistant bacteria].
    Kansenshogaku Zasshi; 2014 Jul; 88(4):409-16. PubMed ID: 25199373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems in the clinical use of antibiotics in China].
    Zhang YX
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):353-4. PubMed ID: 15558845
    [No Abstract]   [Full Text] [Related]  

  • 11. The Whys and Wherefores of Antibiotic Resistance.
    Strachan CR; Davies J
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27793964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and laboratory problems related to the application of antibiotics].
    Xiao YH
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):357-9. PubMed ID: 15559879
    [No Abstract]   [Full Text] [Related]  

  • 13. Over-the-counter delivery of antibiotics: are we sending the right message?
    Al-Hamad A
    Am J Infect Control; 2012 Feb; 40(1):81-2. PubMed ID: 22137194
    [No Abstract]   [Full Text] [Related]  

  • 14. Beginning and possibly the end of the antibiotic era.
    Ashkenazi S
    J Paediatr Child Health; 2013 Mar; 49(3):E179-82. PubMed ID: 23252836
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted killing of virulent Vibrio cholerae.
    Novick R
    Nat Biomed Eng; 2019 Jul; 3(7):507-508. PubMed ID: 31209355
    [No Abstract]   [Full Text] [Related]  

  • 16. Global antimicrobial resistance alerts and implications.
    Levy SB; O'Brien TF;
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S219-20. PubMed ID: 16032554
    [No Abstract]   [Full Text] [Related]  

  • 17. The benefits and risks of mass antibiotic use for reducing child mortality.
    Bhutta ZA
    Nat Med; 2019 Sep; 25(9):1332-1334. PubMed ID: 31501607
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance integrons: class 1, 2 and 3 integrons.
    Deng Y; Bao X; Ji L; Chen L; Liu J; Miao J; Chen D; Bian H; Li Y; Yu G
    Ann Clin Microbiol Antimicrob; 2015 Oct; 14():45. PubMed ID: 26487554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Return of Communicable Diseases as a Result of Antibiotic Resistance?
    Laukkanen MO
    Antioxid Redox Signal; 2021 Feb; 34(6):439-441. PubMed ID: 32977732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics: a new hope.
    Wright GD
    Chem Biol; 2012 Jan; 19(1):3-10. PubMed ID: 22284349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.